A syringe is a piston-like medical instrument that has a significant importance in healthcare. Syringes play a major role in administration of vaccines, nutritional supplements, and medicines. The product has wide range of applicability, from injecting of liquid nutritionals into a feeding tube to conduct vaccination. Syringes can be classified into reusable and disposables. Increasing prevalence of chronic conditions and rising patient population is prominently expected to drive the market growth during the forecast period.
The scope of the syringes market includes procedure syringe type, application, usability, end user, and region. The market for syringe is analyzed based on Asia Pacific regions. The report offers insights and in-depth analysis of the syringes market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Strategic insights for the Asia Pacific Syringe provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 2,654.58 Million |
Market Size by 2027 | US$ 5,946.66 Million |
Global CAGR (2020 - 2027) | 10.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Syringe Type
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
The geographic scope of the Asia Pacific Syringe refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Asia Pacific syringe market is projected to reach US$ 5,946.66 million by 2027 from US$ 2,654.58 million in 2019. The market is estimated to grow at CAGR of 10.5% from 2020 to 2027. The growth of the market is driven by the factors such as, growing number of chronic diseases and infectious diseases and increased adoption of injectable drugs. However, the market is likely to have negative impact due to growing cases of needle-stick injuries.
Based on syringe type, the syringe market is sub segmented into luer lock syringes, glass syringes, luer slip syringes, and others. In 2019, the luer lock syringes segment accounted for the largest share of the market. However, the glass syringes segment is estimated to register the highest CAGR of 11.3% in the market during the forecast period.
Based on application, the market is segmented into aesthetics, human health, lab/industrial, and others. The human health segment held the largest share of the market in 2019; moreover, Aesthetics is segment is estimated to register the highest CAGR of 11.6% in the market during the forecast period.
Based on usability, the market is segmented into sterilizable/reusable syringes and disposable syringes. The disposable syringes segment held the largest share of the market in 2019; moreover, it is estimated to register the highest CAGR of 10.7% in the market during the forecast period.
Based on end user, the market is segmented into hospitals & clinics, blood collection centers, diabetic care centers, and others. The hospitals & clinics segment held the largest share of the market in 2019. However, the diabetic care centers segment is estimated to register the highest CAGR of 11.5% in the market during the forecast period.
Some of the major primary and secondary sources for Asia Pacific syringe market included in the report are, The World Health Organization (WHO), Food and Drug Administration (FDA), United States Nations Department of Economic and Social Affairs, American Society of Plastic Surgeons , U.S. Department of Health and Human Services , Arthritis Foundation , and American Diabetes Association among others.
By Syringes Type
By End User
The Asia Pacific Syringe Market is valued at US$ 2,654.58 Million in 2019, it is projected to reach US$ 5,946.66 Million by 2027.
As per our report Asia Pacific Syringe Market, the market size is valued at US$ 2,654.58 Million in 2019, projecting it to reach US$ 5,946.66 Million by 2027. This translates to a CAGR of approximately 10.5% during the forecast period.
The Asia Pacific Syringe Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Syringe Market report:
The Asia Pacific Syringe Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Syringe Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Syringe Market value chain can benefit from the information contained in a comprehensive market report.